Differential/JJ
Expression/NN
of/IN
PKD2-Associated/JJ
Genes/NNS
in/IN
Autosomal/JJ
Dominant/JJ
Polycystic/JJ
Kidney/NN
Disease/NN
./.
====================
Autosomal/JJ
dominant/JJ
polycystic/JJ
kidney/NN
disease/NN
(/(
ADPKD/NN
)/)
is/VBZ
characterized/VBN
by/IN
formation/NN
of/IN
multiple/JJ
fluid-filled/JJ
cysts/NNS
that/DT
expand/VBP
over/IN
time/NN
and/CC
destroy/IN
renal/JJ
architecture/NN
./.
====================
The/DT
proteins/NNS
encoded/VBN
by/IN
the/DT
PKD1/NN
and/CC
PKD2/NN
genes/NNS
,/,
mutations/NNS
in/IN
which/WDT
account/VBP
for/IN
nearly/RB
all/DT
cases/NNS
of/IN
ADPKD/NN
,/,
may/MD
help/VB
guard/NN
against/IN
cystogenesis/NN
./.
====================
Previously/RB
developed/VBD
mouse/NN
models/NNS
of/IN
PKD1/NN
and/CC
PKD2/NN
demonstrated/VBD
an/DT
embryonic/JJ
lethal/JJ
phenotype/NN
and/CC
massive/JJ
cyst/NN
formation/NN
in/IN
the/DT
kidney/NN
,/,
indicating/VBG
that/IN
PKD1/NN
and/CC
PKD2/NN
probably/RB
play/VBP
important/JJ
roles/NNS
during/IN
normal/JJ
renal/JJ
tubular/JJ
development/NN
./.
====================
However/RB
,/,
their/PRP$
precise/JJ
role/NN
in/IN
development/NN
and/CC
the/DT
cellular/JJ
mechanisms/NNS
of/IN
cyst/NN
formation/NN
induced/VBN
by/IN
PKD1/NN
and/CC
PKD2/NN
mutations/NNS
are/VBP
not/RB
fully/RB
understood/VBN
./.
====================
To/TO
address/VB
this/DT
question/NN
,/,
we/PRP
presently/RB
created/VBD
Pkd2/NN
knockout/JJ
and/CC
PKD2/NN
transgenic/JJ
mouse/NN
embryo/NN
fibroblasts/NNS
./.
====================
We/PRP
used/VBD
a/DT
mouse/NN
oligonucleotide/NN
microarray/NN
to/TO
identify/VB
messenger/NN
RNAs/NNS
whose/WP$
expression/NN
was/VBD
altered/JJ
by/IN
the/DT
overexpression/NN
of/IN
the/DT
PKD2/NN
or/CC
knockout/JJ
of/IN
the/DT
Pkd2/NN
./.
====================
The/DT
majority/NN
of/IN
identified/VBN
mutations/NNS
was/VBD
involved/VBN
in/IN
critical/JJ
biological/JJ
processes/NNS
,/,
such/JJ
as/IN
metabolism/NN
,/,
transcription/NN
,/,
cell/NN
adhesion/NN
,/,
cell/NN
cycle/NN
,/,
and/CC
signal/NN
transduction/NN
./.
====================
Herein/RB
,/,
we/PRP
confirmed/VBD
differential/JJ
expressions/NNS
of/IN
several/JJ
genes/NNS
including/VBG
aquaporin-1/NN
,/,
according/VBG
to/TO
different/JJ
PKD2/NN
expression/NN
levels/NNS
in/IN
ADPKD/NN
mouse/NN
models/NNS
,/,
through/IN
microarray/NN
analysis/NN
./.
====================
These/DT
data/NNS
may/MD
be/VB
helpful/JJ
in/IN
PKD2-related/JJ
mechanisms/NNS
of/IN
ADPKD/NN
pathogenesis/NN
./.
====================
Autosomal/JJ
dominant/JJ
polycystic/JJ
kidney/NN
disease/NN
(/(
ADPKD/NN
)/)
is/VBZ
a/DT
common/JJ
monogenetic/JJ
disorder/NN
,/,
affecting/VBG
as/IN
many/JJ
as/IN
1/CD
in/IN
500/CD
people/NN
in/IN
the/DT
general/JJ
population/NN
./.
====================
The/DT
disease/NN
is/VBZ
characterized/VBN
by/IN
the/DT
formation/NN
of/IN
multiple/JJ
fluid-filled/JJ
renal/JJ
cysts/NNS
that/DT
expand/VBP
over/IN
time/NN
and/CC
destroy/IN
the/DT
architecture/NN
of/IN
the/DT
kidney/NN
./.
====================
Five/CD
percent/JJ
of/IN
all/DT
cases/NNS
of/IN
chronic/JJ
renal/JJ
failure/NN
are/VBP
due/JJ
to/TO
ADPKD/NN
,/,
and/CC
approximately/RB
50/CD
%/NN
of/IN
ADPKD/NN
patients/NNS
will/MD
develop/VB
end-stage/JJ
renal/JJ
disease/NN
by/IN
the/DT
time/NN
they/PRP
are/VBP
60/CD
years/NNS
of/IN
age/NN
[/(
1/CD
]/)
./.
====================
In/IN
the/DT
early/JJ
stages/NNS
of/IN
ADPKD/NN
,/,
numerous/JJ
cysts/NNS
begin/NN
to/TO
enlarge/VB
from/IN
many/JJ
segments/NNS
of/IN
the/DT
kidney/NN
./.
====================
Later/JJ
,/,
the/DT
enlarged/JJ
regions/NNS
disassociate/VBP
from/IN
the/DT
original/JJ
nephron/NN
to/TO
form/VB
the/DT
actual/JJ
cysts/NNS
,/,
which/WDT
continue/VBP
to/TO
enlarge/VB
due/JJ
to/TO
proliferation/NN
of/IN
epithelial/JJ
cells/NNS
and/CC
fluid/NN
secretion/NN
into/IN
the/DT
cyst/NN
lumen/NNS
./.
====================
Progressive/JJ
renal/JJ
cyst/NN
formation/NN
and/CC
enlargement/JJ
result/NN
in/IN
a/DT
loss/NN
of/IN
renal/JJ
function/NN
and/CC
hypertension/NN
and/CC
culminate/VBP
in/IN
renal/JJ
failure/NN
./.
====================
It/PRP
is/VBZ
generally/RB
believed/VBN
that/IN
cysts/NNS
enlarge/JJ
by/IN
means/NNS
of/IN
abnormal/JJ
cell/NN
growth/NN
,/,
forming/VBG
what/WP
is/VBZ
essentially/RB
a/DT
fluid-filled/JJ
tumor/NN
that/DT
fills/NNS
by/IN
transepithelial/JJ
fluid/NN
secretion/NN
./.
====================
Cyst/RB
enlargement/JJ
may/MD
then/RB
lead/VBP
to/TO
extracellular/JJ
matrix/NN
remodeling/NN
,/,
interstitial/JJ
fibrosis/NN
,/,
a/DT
general/JJ
inflammatory/JJ
response/NN
,/,
and/CC
disruption/NN
of/IN
the/DT
normal/JJ
renal/JJ
parenchyma/NN
,/,
which/WDT
then/RB
interfere/VBP
with/IN
glomerular/JJ
filtration/NN
and/CC
vascular/JJ
blood/NN
flow/NN
,/,
giving/VBG
rise/NN
to/TO
cell/NN
death/NN
by/IN
apoptosis/NN
and/CC
ultimately/RB
renal/JJ
failure/NN
[/(
2/CD
]/)
./.
====================
Many/JJ
studies/NNS
have/VBP
indicated/VBN
that/IN
most/JJS
cases/NNS
of/IN
ADPKD/NN
are/VBP
accounted/VBN
for/IN
by/IN
mutations/NNS
in/IN
the/DT
PKD1/NN
and/CC
PKD2/NN
genes/NNS
,/,
encoding/VBG
the/DT
transmembrane/JJ
protein/NN
polycystin-1/NN
(/(
PC1/NN
)/)
and/CC
polycystin-2/NN
(/(
PC2/NN
)/)
,/,
respectively/RB
./.
====================
Mice/NNS
with/IN
targeted/VBN
mutations/NNS
in/IN
the/DT
PKD1/NN
or/CC
PKD2/NN
genes/NNS
develop/VBP
cystic/JJ
kidneys/NNS
during/IN
embryogenesis/NN
,/,
and/CC
ADPKD/NN
in/IN
humans/NNS
is/VBZ
associated/VBN
with/IN
mutations/NNS
in/IN
the/DT
PKD1/NN
or/CC
PKD2/NN
genes/NNS
[/(
3/CD
,/,
4/CD
]/)
./.
====================
In/IN
addition/NN
,/,
the/DT
product/NN
of/IN
the/DT
PKD1/NN
gene/NN
,/,
PC1/NN
,/,
has/VBZ
been/VBN
implicated/VBN
in/IN
a/DT
variety/NN
of/IN
pathways/NNS
tied/VBN
to/TO
proliferation/NN
,/,
including/VBG
G-protein/NN
signaling/NN
and/CC
the/DT
Wnt/NN
,/,
activator/NN
protein/NN
1/CD
(/(
AP-1/NN
)/)
,/,
and/CC
Janus/NN
kinase-signal/JJ
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
cascades/NNS
[/(
5/CD
,/,
6/CD
]/)
./.
====================
Moreover/RB
,/,
depletion/NN
of/IN
PC1/NN
has/VBZ
been/VBN
shown/VBN
to/TO
increase/VB
cell/NN
growth/NN
,/,
whereas/IN
its/PRP$
overexpression/NN
slows/VBZ
cell/NN
growth/NN
,/,
indicating/VBG
that/IN
PC1/NN
may/MD
negatively/RB
regulate/VB
cell/NN
proliferation/NN
[/(
7/CD
,/,
8/CD
]/)
./.
====================
PC2/NN
,/,
the/DT
protein/NN
product/NN
of/IN
PKD2/NN
,/,
has/VBZ
also/RB
been/VBN
implicated/VBN
in/IN
cell/NN
cycle/NN
regulation/NN
via/IN
its/PRP$
calcium/NN
channel/NN
activity/NN
and/CC
stimulation/NN
of/IN
AP-1/NN
[/(
9/CD
,/,
10/CD
]/)
;/:
however/RB
,/,
there/EX
has/VBZ
been/VBN
little/JJ
direct/JJ
evidence/NN
tying/VBG
PC2/NN
to/TO
this/DT
process/NN
./.
====================
Here/RB
,/,
we/PRP
created/VBD
a/DT
number/NN
of/IN
related/JJ
cell/NN
lines/NNS
that/WDT
varied/VBD
in/IN
their/PRP$
expression/NN
of/IN
PC2/NN
./.
====================
We/PRP
describe/VBP
studies/NNS
designed/VBD
to/TO
identify/VB
target/NN
genes/NNS
under/IN
the/DT
control/NN
of/IN
the/DT
PKD2/NN
using/VBG
Pkd2/NN
knockout/JJ
(/(
KO/NN
)/)
and/CC
PKD2/NN
transgenic/JJ
(/(
TG/NN
)/)
mouse/NN
embryo/NN
fibroblasts/NNS
(/(
MEFs/NNS
)/)
./.
====================
We/PRP
used/VBD
a/DT
mouse/NN
30/CD
K/NN
whole/JJ
gene/NN
oligonucleotide/NN
microarray/NN
to/TO
identify/VB
messenger/NN
RNAs/NNS
whose/WP$
expression/NN
was/VBD
altered/JJ
by/IN
the/DT
overexpression/NN
of/IN
the/DT
PKD2/NN
or/CC
KO/NN
of/IN
the/DT
Pkd2/NN
in/IN
MEF/NN
cells/NNS
./.
====================
Establishment/JJ
of/IN
MEF/NN
derived/VBN
from/IN
wild-type/JJ
and/CC
PKD2/NN
mutation/NN
embryos/NNS
====================
MEF/NN
were/VBD
acquired/VBN
from/IN
PKD2/NN
TG/NN
embryos/NNS
or/CC
Pkd2/NN
KO/NN
embryos/NNS
during/IN
development/NN
(/(
13.5/CD
days/NNS
)/)
[/(
11/CD
]/)
./.
====================
Heads/NNS
and/CC
limes/NNS
were/VBD
removed/VBN
from/IN
embryos/NNS
./.
====================
The/DT
remaining/VBG
embryonic/JJ
tissues/NNS
were/VBD
minced/VBN
and/CC
dispersed/JJ
in/IN
0.05/CD
%/NN
trypsin/NN
prior/JJ
to/TO
incubation/NN
at/IN
37℃/CD
for/IN
15/CD
min/NN
./.
====================
Cells/NNS
were/VBD
plated/VBN
in/IN
Dulbecco/NN
's/POS
Modified/JJ
Eagle/JJ
's/POS
Medium/NN
of/IN
Defined/JJ
Minimal/JJ
Essential/JJ
medium/NN
(/(
Welgene/NN
Biotech/NNP
,/,
Taipei/NNP
,/,
Taiwan/NNP
)/)
supplemented/VBD
with/IN
10/CD
%/NN
fetal/JJ
bovine/NN
serum/NN
(/(
Welgene/NN
Biotech/NNP
)/)
and/CC
were/VBD
cultured/VBN
at/IN
37℃/CD
in/IN
an/DT
atmosphere/JJ
of/IN
5/CD
%/NN
CO2/NN
until/IN
confluent/JJ
growth/NN
was/VBD
achieved/VBN
./.
====================
MEF/NN
cells/NNS
were/VBD
frozen/VBN
as/IN
stocks/NNS
at/IN
the/DT
second/JJ
passage/NN
and/CC
were/VBD
used/VBN
for/IN
the/DT
subsequent/JJ
studies/NNS
at/IN
the/DT
third/JJ
passage/NN
./.
====================
Microrray/NN
hybridization/NN
and/CC
data/NNS
analysis/NN
====================
Total/JJ
RNA/NN
was/VBD
prepared/VBN
using/VBG
a/DT
commercial/JJ
kit/NN
(/(
Qiagen/NN
,/,
Valancia/NN
,/,
CA/NN
,/,
USA/NN
)/)
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
Gene/NN
expression/NN
profiles/NNS
were/VBD
obtained/VBN
using/VBG
the/DT
CodeLink/NN
Uniset/JJ
Mouse/NN
Expression/NN
Bioarray/NN
(/(
Amersham/NN
,/,
Buckinghamshire/NNP
,/,
UK/NN
)/)
./.
====================
The/DT
30,000/CD
gene/NN
probes/NNS
contained/VBD
in/IN
the/DT
bioarray/NN
allows/VBZ
the/DT
detection/NN
of/IN
differences/NNS
in/IN
gene/NN
expression/NN
as/IN
low/JJ
as/IN
1.3-fold/RB
with/IN
95/CD
%/NN
confidence/NN
./.
====================
Ten/CD
micrograms/NNS
of/IN
total/JJ
RNA/NN
was/VBD
amplified/VBN
,/,
and/CC
labeled/VBN
cDNA/NN
was/VBD
produced/VBN
./.
====================
Biotin-labeled/JJ
cDNA/NN
was/VBD
hybridized/VBN
to/TO
the/DT
array/NN
overnight/JJ
in/IN
a/DT
shaking/JJ
incubator/NN
at/IN
37℃/CD
,/,
and/CC
excess/NN
target/NN
sequences/NNS
were/VBD
washed/VBN
away/NN
using/VBG
a/DT
series/NN
of/IN
saline/NN
sodium/NN
citrate/NN
washes/NNS
./.
====================
The/DT
array/NN
was/VBD
stained/VBN
by/IN
treatment/NN
with/IN
streptavidin-Alexaflour/JJ
647/CD
(/(
Molecular/JJ
Probes/NNS
,/,
Eugene/NN
,/,
OR/NN
,/,
USA/NNP
)/)
,/,
the/DT
excess/NN
was/VBD
washed/VBN
away/NN
,/,
and/CC
the/DT
array/NN
was/VBD
scanned/VBN
at/IN
an/DT
excitation/NN
wavelength/NN
of/IN
632/CD
nm/NN
using/VBG
a/DT
GenePix/JJ
scanner/NN
(/(
Molecular/JJ
Devices/NNS
,/,
Sunnyvale/JJ
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
The/DT
resulting/VBG
image/NN
was/VBD
quantified/VBN
,/,
and/CC
the/DT
intensity/NN
of/IN
each/DT
spot/NN
was/VBD
divided/VBN
by/IN
the/DT
median/JJ
spot/NN
intensity/NN
to/TO
provide/VB
a/DT
scaled/JJ
and/CC
comparable/JJ
number/NN
across/IN
multiple/JJ
arrays/NNS
./.
====================
DNA/NN
microarray/NN
scanning/NN
and/CC
analysis/NN
====================
Microarrays/NNS
were/VBD
scanned/VBN
using/VBG
an/DT
Arraywox/NN
scanner/NN
(/(
Applied/VBN
Precision/NN
,/,
Seattle/JJ
,/,
WA/NN
,/,
USA/NNP
)/)
,/,
analyzed/VBD
using/VBG
ImaGene/JJ
version/NN
5.1/CD
software/RB
(/(
Biodiscovery/NNP
,/,
Segundo/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
,/,
and/CC
normalized/VBD
using/VBG
Genesight/NN
version/NN
3.2/CD
software/RB
(/(
Biodiscovery/NNP
)/)
./.
====================
Normalization/NN
was/VBD
performed/VBN
by/IN
subtracting/VBG
the/DT
means/NNS
of/IN
all/DT
genes/NNS
./.
====================
The/DT
data/NNS
normalized/VBD
by/IN
Genesight/NN
were/VBD
compared/VBN
using/VBG
an/DT
M/A/NN
plot/NN
./.
====================
Genes/NNS
differentially/RB
expressed/VBN
were/VBD
identified/VBN
by/IN
intensity/NN
differences/NNS
,/,
after/IN
subtracting/VBG
the/DT
background/NN
intensity/NN
./.
====================
Genes/NNS
showing/VBG
expression/NN
changes/NNS
of/IN
at/IN
least/JJS
2-fold/JJ
were/VBD
selected/VBN
,/,
and/CC
these/DT
selected/VBN
genes/NNS
were/VBD
clustered/VBN
by/IN
the/DT
hierarchical/JJ
method/NN
./.
====================
Clustering/NN
algorithm/NN
====================
The/DT
normalized/VBN
log/NN
ratio/NN
corresponding/VBG
to/TO
each/DT
time/NN
point/NN
was/VBD
exported/VBN
to/TO
the/DT
software/JJ
for/IN
clustering/NN
algorithm/NN
./.
====================
Acuity/NN
version/NN
3.1/CD
(/(
Molecular/JJ
Devices/NNS
)/)
was/VBD
used/VBN
for/IN
the/DT
'gene/NN
shaving/VBG
'/``
algorithm/NN
./.
====================
To/TO
estimate/VB
the/DT
number/NN
of/IN
clusters/NNS
in/IN
a/DT
dataset/NN
,/,
the/DT
'Gap/JJ
Statistics/NNS
'/``
attribute/VBP
of/IN
the/DT
Acuity/NN
software/JJ
package/NN
was/VBD
used/VBN
./.
====================
The/DT
cluster/NN
number/NN
,/,
estimated/VBN
by/IN
gap/NN
statistics/NNS
,/,
was/VBD
used/VBN
for/IN
an/DT
input/NN
parameter/NN
in/IN
gene/NN
shaving/VBG
./.
====================
After/IN
gene/NN
shaving/VBG
,/,
a/DT
single/JJ
linkage/NN
was/VBD
used/VBN
for/IN
hierarchical/JJ
clustering/NN
./.
====================
Semi-quantitative/JJ
and/CC
real-time/VBP
RT-PCR/NN
====================
Total/JJ
RNA/NN
was/VBD
prepared/VBN
using/VBG
a/DT
commercial/JJ
kit/NN
(/(
Qiagen/NN
)/)
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
Single-strand/CC
cDNA/NN
was/VBD
synthesized/VBN
by/IN
incubating/VBG
5/CD
µg/NN
total/JJ
RNA/NN
with/IN
200/CD
units/NNS
AMV/NN
,/,
100/CD
nM/NN
oligo/JJ
(/(
dT/JJ
)/)
12-18/CD
,/,
1/CD
mM/NN
dNTP/NN
mixture/NN
,/,
and/CC
40/CD
units/NNS
RNase/NN
inhibitor/NN
at/IN
42℃/CD
for/IN
1/CD
h/NN
in/IN
a/DT
final/JJ
volume/NN
of/IN
25/CD
µL/NN
./.
====================
The/DT
reaction/NN
was/VBD
terminated/VBN
by/IN
incubation/NN
at/IN
70℃/CD
for/IN
15/CD
min/NN
./.
====================
The/DT
initial/JJ
amount/NN
of/IN
mRNA/NN
and/CC
reaction/NN
conditions/NNS
were/VBD
optimized/VBN
to/TO
obtain/VB
linearity/NN
for/IN
mouse/NN
18s/CD
rRNA/NN
./.
====================
For/IN
semi-quantitative/JJ
reverse/JJ
transcription/NN
(/(
RT/NN
)/)
-PCR/NN
,/,
the/DT
used/VBN
primers/NNS
were/VBD
:/:
human/JJ
PKD2/NN
,/,
forward/IN
5'-CGTGCCCCAGCCCAGTC-3/NN
'/``
and/CC
reverse/JJ
5'-TTCCAGTACAGCCCATCCAATAAG-3/NN
'/``
;/:
mouse/NN
Pkd2/NN
,/,
forward/IN
5'-TGCGAGGGCTGCGAGGTC-3/NN
'/``
and/CC
reverse/JJ
5'-TGTCAGCTTGCGTGTGGTTGC-3/NN
'/``
;/:
mouse/NN
18s/CD
rRNA/NN
,/,
forward/IN
5'-GTAACCCGTTGCACCCCATT-3/NN
'/``
and/CC
reverse/JJ
5'-CCATCCAATCGGTAGTAGCG-3/NN
'/``
./.
====================
RT-PCR/NN
cycling/NN
conditions/NNS
were/VBD
as/IN
follows/VBZ
:/:
10/CD
min/NN
at/IN
95℃/CD
,/,
25/CD
cycles/NNS
of/IN
50/CD
s/NNS
at/IN
94℃/CD
,/,
50/CD
s/NNS
at/IN
57℃/CD
,/,
50/CD
s/NNS
at/IN
72℃/CD
,/,
and/CC
5/CD
min/NN
at/IN
72℃/CD
./.
====================
The/DT
amplified/VBN
products/NNS
were/VBD
separated/VBN
on/IN
a/DT
1/CD
%/NN
agarose/NN
gel/NN
./.
====================
For/IN
real-time/RB
PCR/NN
,/,
the/DT
used/VBN
primers/NNS
were/VBD
:/:
mouse/RB
β-actin/RB
,/,
(/(
forward/IN
5'-GACGATGCTCCCCGGGCTGTATTC-3/NN
'/``
and/CC
reverse/JJ
5'-TCTCTTGCTCTGGGCCTCGTCACC-3/NN
'/``
)/)
used/VBN
as/IN
a/DT
positive/JJ
control/JJ
;/:
mouse/RB
peroxisome/DT
proliferator-activated/JJ
receptor/NN
γ/RB
(/(
PPAR-γ/NNP
)/)
,/,
forward/IN
5'-TCTTAACTGCCGGATCCACAAAAA-3/NN
'/``
and/CC
reverse/JJ
5'-ATCTCCGCCAACAGCTTCTCCTTC-3/NN
'/``
;/:
mouse/RB
protein/NN
kinase/NN
α/RB
(/(
PKCα/NNP
)/)
,/,
forward/IN
5'-GGGCAGCCTCCGTTTGATGGT-3/NN
'/``
and/CC
reverse/JJ
5'-CGCTTGGCAGGGTGTTTGGTC-3/NN
'/``
;/:
mouse/RB
Wnt4/NN
,/,
forward/IN
5'-GCCATCGAGGAGTGCCAATACC-3/NN
'/``
and/CC
reverse/JJ
5'-GGCCACACCTGCTGAAGAGATG-3/JJ
'/``
;/:
mouse/RB
integrin/NN
α4/RB
(/(
ITGα4/NNP
)/)
,/,
forward/IN
5'-GTAGCCCCAGTGGAGAGCCTTGTG-3/NN
'/``
and/CC
reverse/JJ
5'-ATGCCAGTGGGGAGTTTGTTATCG-3/JJ
'/``
;/:
mouse/RB
IL6ST/NN
,/,
forward/IN
5'-TGAATCGGACCCACTTGAGAGG-3/NN
'/``
and/CC
reverse/JJ
5'-CAGGAGCGGCTTGTTTGAGGTA-3/NN
'/``
;/:
mouse/RB
aquaporin/IN
1/LS
(/(
AQP1/NNP
)/)
,/,
forward/IN
5'-GGAGGCGCCGAGACTTAGGT-3/NN
'/``
and/CC
reverse/JJ
5'-GCGGGTGAGCACAGCAGAGC-3/NN
'/``
;/:
mouse/RB
transforming/VBG
growth/NN
factor-β2/RB
(/(
TGF-β2/NNP
)/)
,/,
forward/IN
5'-TCATCCCGAATAAAAGCGAAGAGC-3/NN
'/``
and/CC
reverse/JJ
5'-AGGGCAACAACATTAGCAGGAGAT-3/JJ
'/``
./.
====================
Real-time/NN
RT-PCR/NN
was/VBD
performed/VBN
using/VBG
the/DT
real-time/NN
SensiMixPlus/NN
SYBR/NN
kit/NN
as/IN
described/VBN
by/IN
the/DT
manufacturer/NN
's/POS
instructions/NNS
(/(
Quantance/NN
,/,
London/JJ
,/,
UK/NN
)/)
./.
====================
Western/NN
blot/NN
analysis/NN
====================
Proteins/NNS
were/VBD
extracted/VBN
using/VBG
radio-immunoprecipitation/NN
assay/NN
buffer/NN
in/IN
MEF/NN
cells/NNS
./.
====================
Proteins/NNS
were/VBD
separated/VBN
by/IN
12/CD
%/NN
sodium/NN
dodecyl/NN
sulfate-polyacryamide/NN
gel/NN
electrophoresis/NN
and/CC
were/VBD
transferred/VBN
to/TO
a/DT
polyvinylidene/JJ
fluoride/NN
membrane/NN
(/(
Millipore/RBR
,/,
Bellerica/NNP
,/,
MA/NN
,/,
USA/NN
)/)
./.
====================
Membranes/NNS
were/VBD
blocked/VBN
with/IN
5/CD
%/NN
non-fat/JJ
dry/JJ
milk/NN
and/CC
were/VBD
incubated/VBN
with/IN
various/JJ
antibodies/NNS
./.
====================
Antibodies/NNS
to/TO
PC2/NN
(/(
anti-human/JJ
and/CC
anti-mouse/JJ
)/)
and/CC
AQP1/NN
were/VBD
obtained/VBN
from/IN
Santa/NN
Cruz/NN
Biotechnology/NN
(/(
Santa/NN
Cruz/NN
,/,
CA/NNP
,/,
USA/NN
)/)
./.
====================
Antibodies/NNS
to/TO
β-actin/NN
were/VBD
obtained/VBN
from/IN
Sigma-Aldrich/JJ
(/(
St./NNP
Louis/NN
,/,
MO/NN
,/,
USA/NN
)/)
./.
====================
Anti-Wnt4/NN
was/VBD
obtained/VBN
from/IN
R/NN
&/CC
D/NN
Systems/NNS
(/(
Minneapolis/NN
,/,
MN/NN
,/,
USA/NN
)/)
./.
====================
Each/DT
membrane/NN
was/VBD
washed/VBN
with/IN
phosphate-buffered/VBN
saline-Tween/NN
,/,
and/CC
immunocomplexes/NNS
were/VBD
detected/VBN
by/IN
enhanced/VBN
chemiluminescence/NN
(/(
Amersham/NN
)/)
./.
====================
Confirmation/NN
of/IN
PKD2/NN
expression/NN
in/IN
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEFs/NNS
====================
Mouse/NN
Pkd2/NN
mRNA/NN
was/VBD
revealed/VBN
in/IN
KO/NN
wild-type/JJ
(/(
KOWT/NN
)/)
MEF/NN
cells/NNS
but/CC
not/RB
in/IN
KO/NN
MEF/NN
cells/NNS
./.
====================
Also/RB
,/,
Pkd2/NN
mRNA/NN
was/VBD
expressed/VBN
in/IN
TG/NN
wild-type/JJ
(/(
TGWT/NN
)/)
MEF/NN
cells/NNS
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
Human/JJ
PKD2/NN
mRNA/NN
was/VBD
only/RB
expressed/VBN
in/IN
PKD2/NN
TG/NN
MEF/NN
cells/NNS
obtained/VBN
from/IN
PKD2/NN
TG/NN
embryos/NNS
following/VBG
injection/NN
of/IN
the/DT
human/JJ
PKD2/NN
transgene/NN
(/(
Fig/NN
./.
====================
1A/NN
)/)
./.
====================
Consistently/RB
,/,
the/DT
expression/NN
level/NN
of/IN
polycystin-2/NN
was/VBD
lower/JJR
in/IN
KO/NN
MEFs/NNS
than/IN
KOWT/NN
MEFs/NNS
as/IN
well/RB
as/IN
higher/JJR
in/IN
TG/NN
MEFs/NNS
than/IN
TGWT/NN
MEFs/NNS
(/(
Fig/NN
./.
====================
1B/NN
)/)
./.
====================
Microarray/NN
gene/NN
expression/NN
analysis/NN
====================
We/PRP
used/VBD
a/DT
mouse/NN
30/CD
K/NN
whole/JJ
gene/NN
oligonucleotide/NN
microarray/NN
to/TO
identify/VB
mRNAs/NNS
whose/WP$
expression/NN
was/VBD
altered/JJ
by/IN
the/DT
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
The/DT
normalized/VBN
log/NN
ratios/NNS
corresponding/VBG
to/TO
each/DT
time/NN
point/NN
were/VBD
exported/VBN
to/TO
the/DT
software/JJ
for/IN
clustering/NN
algorithm/NN
./.
====================
We/PRP
used/VBD
Axon/JJ
's/POS
Acuity/NN
3.1/CD
(/(
Axon/JJ
Instruments/NNS
,/,
Union/JJ
City/NN
,/,
CA/NNP
,/,
USA/NN
)/)
for/IN
using/VBG
the/DT
'gene/NN
shaving/VBG
'/``
algorithm/NN
./.
====================
To/TO
estimate/VB
the/DT
number/NN
of/IN
clusters/NNS
in/IN
a/DT
dataset/NN
,/,
we/PRP
used/VBD
'Gap/JJ
Statistics/NNS
'/``
in/IN
Acuity/NN
3.1/CD
./.
====================
The/DT
cluster/NN
number/NN
estimated/VBN
by/IN
gap/NN
statistics/NNS
was/VBD
used/VBN
for/IN
an/DT
input/NN
parameter/NN
in/IN
gene/NN
shaving/VBG
./.
====================
After/IN
gene/NN
shaving/VBG
,/,
we/PRP
used/VBD
a/DT
single/JJ
linkage/NN
hierarchical/JJ
clustering/NN
./.
====================
The/DT
single/JJ
linkage/NN
hierarchical/JJ
clustering/NN
method/NN
divides/NNS
8/CD
'gene/NN
shaving/VBG
'/``
clusters/NNS
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
The/DT
majority/NN
of/IN
genes/NNS
whose/WP$
expression/NN
was/VBD
appreciably/RB
altered/JJ
encoded/VBN
proteins/NNS
involved/VBN
in/IN
critical/JJ
biological/JJ
processes/NNS
,/,
such/JJ
as/IN
metabolism/NN
,/,
transcription/NN
,/,
cell/NN
adhesion/NN
,/,
cell/NN
cycle/NN
,/,
and/CC
signal/NN
transcription/NN
./.
====================
Forty-five/JJ
genes/NNS
whose/WP$
expression/NN
was/VBD
changed/VBN
by/IN
2-fold/JJ
or/CC
greater/JJR
were/VBD
identified/VBN
(/(
Table/JJ
1/CD
)/)
./.
====================
Verification/NN
of/IN
candidate/NN
genes/NNS
by/IN
quantitative/JJ
RT-PCR/NN
and/CC
immunoblot/NN
analysis/NN
====================
To/TO
verify/VB
the/DT
results/NNS
obtained/VBN
by/IN
cDNA/NN
microarray/NN
analysis/NN
,/,
expression/NN
patterns/NNS
for/IN
selected/VBN
genes/NNS
were/VBD
confirmed/VBN
at/IN
the/DT
RNA/NN
and/CC
protein/NN
levels/NNS
./.
====================
We/PRP
selected/VBD
seven/CD
genes/NNS
among/IN
the/DT
45/CD
genes/NNS
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
As/IN
result/NN
of/IN
realtime/JJ
RT-PCR/NN
,/,
the/DT
expression/NN
patterns/NNS
of/IN
PKCα/JJ
,/,
ITGα4/NN
,/,
and/CC
AQP1/NN
were/VBD
identical/JJ
to/TO
microarray/NN
analysis/NN
in/IN
Pkd2/NN
KO/NN
MEF/NN
cells/NNS
(/(
Fig/NN
./.
====================
3B/NN
)/)
./.
====================
In/IN
contrast/NN
,/,
6/CD
genes/NNS
,/,
except/IN
for/IN
TGF-β2/NN
,/,
were/VBD
identically/RB
expressed/VBN
in/IN
PKD2/NN
TG/NN
MEF/NN
cells/NNS
(/(
Fig/NN
./.
====================
3C/NN
)/)
./.
====================
Especially/RB
,/,
the/DT
AQP1/NN
gene/NN
may/MD
be/VB
significantly/RB
regulated/VBN
by/IN
differential/JJ
Pkd2/NN
gene/NN
expression/NN
level/NN
./.
====================
Furthermore/RB
,/,
to/TO
confirm/VB
the/DT
AQP1/NN
protein/NN
expression/NN
level/NN
,/,
western/NN
blot/NN
analysis/NN
was/VBD
performed/VBN
using/VBG
MEF/NN
cells/NNS
as/IN
well/RB
as/IN
kidney/NN
tissues/NNS
obtained/VBN
from/IN
Pkd2/NN
KO/NN
(/(
or/CC
heterozygote/NN
)/)
and/CC
PKD2/NN
TG/NN
mice/NNS
./.
====================
As/IN
result/NN
,/,
AQP1/NN
protein/NN
level/NN
was/VBD
consistent/JJ
with/IN
mRNA/NN
levels/NNS
in/IN
both/CC
MEFs/NNS
and/CC
tissues/NNS
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
Although/IN
remarkable/JJ
progress/VBP
toward/IN
understanding/VBG
the/DT
genetics/NNS
and/CC
pathophysiology/NN
of/IN
ADPKD/NN
has/VBZ
been/VBN
made/VBN
to/TO
date/NN
,/,
it/PRP
is/VBZ
still/RB
unclear/JJ
how/WRB
mutations/NNS
in/IN
disease-causing/VBG
genes/NNS
trigger/VBP
cystogenesis/NN
and/CC
what/WP
important/JJ
role/NN
other/JJ
molecules/NNS
play/VBP
in/IN
the/DT
cystic/JJ
phenotype/NN
[/(
12/CD
]/)
./.
====================
Our/PRP$
aim/NN
here/RB
was/VBD
to/TO
identify/VB
genes/NNS
associated/VBN
with/IN
the/DT
cystic/JJ
phenotype/NN
using/VBG
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
In/IN
a/DT
previous/JJ
study/NN
,/,
overexpression/NN
of/IN
human/JJ
PKD2/NN
led/VBD
to/TO
anomalies/NNS
in/IN
tubular/JJ
function/NN
,/,
due/JJ
to/TO
abnormalities/NNS
in/IN
tubule/NN
morphogenesis/NN
[/(
13/CD
]/)
./.
====================
Similar/JJ
findings/NNS
have/VBP
been/VBN
made/VBN
for/IN
the/DT
PKD1/NN
gene/NN
./.
====================
For/IN
this/DT
gene/NN
,/,
gain/loss/IN
of/IN
function/NN
and/CC
haploinsufficiency/NN
leads/VBZ
to/TO
cystogenesis/NN
,/,
with/IN
the/DT
severity/NN
of/IN
the/DT
phenotype/NN
being/VBG
related/JJ
to/TO
the/DT
level/NN
of/IN
imbalance/NN
./.
====================
More/RBR
severe/JJ
phenotypes/NNS
are/VBP
seen/VBN
for/IN
gain/NN
and/CC
loss/NN
of/IN
function/NN
than/IN
for/IN
haploinsufficiency/NN
[/(
4/CD
]/)
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
the/DT
association/NN
between/IN
cystogenesis/NN
and/CC
the/DT
loss/NN
or/CC
gain/NN
of/IN
PKD2/NN
supports/VBZ
the/DT
idea/NN
that/IN
PC2/NN
functions/NNS
through/IN
Pkd2/NN
mutant/JJ
MEF/NN
cells/NNS
./.
====================
Presently/RB
,/,
we/PRP
found/VBD
Wnt4/NN
to/TO
be/VB
up-regulated/VBN
in/IN
Pkd2/NN
KO/NN
MEF/NN
cells/NNS
and/CC
down-regulated/VBN
in/IN
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
Wnt4/NN
,/,
a/DT
member/NN
of/IN
the/DT
Wnt/NN
family/NN
of/IN
lipid-modified/JJ
secreted/VBN
glycoproteins/NNS
,/,
plays/VBZ
central/JJ
roles/NNS
in/IN
the/DT
initial/JJ
stages/NNS
of/IN
the/DT
tubulogenic/JJ
program/NN
./.
====================
Wnt4/NN
is/VBZ
expressed/VBN
in/IN
the/DT
pretubular/JJ
aggregate/NN
,/,
as/IN
one/CD
of/IN
the/DT
first/JJ
molecular/JJ
responses/NNS
to/TO
inductive/JJ
signaling/NN
mediated/VBN
by/IN
ureteric/JJ
epithelium/NN
[/(
14/CD
]/)
./.
====================
AQP1/NN
was/VBD
observed/VBN
to/TO
be/VB
up-regulated/VBN
in/IN
both/CC
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
AQP1/NN
is/VBZ
a/DT
channel-forming/JJ
integral/JJ
membrane/NN
protein/NN
found/VBN
in/IN
erythrocytes/NNS
and/CC
water-transporting/VBG
tissues/NNS
,/,
including/VBG
the/DT
kidney/NN
,/,
where/WRB
it/PRP
is/VBZ
localized/VBN
to/TO
the/DT
proximal/JJ
tubules/NNS
and/CC
thin/NN
descending/VBG
limbs/NNS
of/IN
Henle/JJ
's/POS
loop/NN
./.
====================
The/DT
selective/JJ
expression/NN
pattern/NN
of/IN
AQP1/NN
in/IN
human/JJ
nephrogenesis/NN
suggests/VBZ
that/IN
proximal/JJ
tubules/NNS
and/CC
thin/NN
descending/VBG
limbs/NNS
become/VBP
permeable/JJ
to/TO
water/NN
early/JJ
in/IN
development/NN
./.
====================
A/DT
predominantly/RB
apical/JJ
expression/NN
of/IN
AQP1/NN
is/VBZ
found/VBN
during/IN
a/DT
critical/JJ
period/NN
of/IN
the/DT
nephrogenesis/NN
,/,
during/IN
formation/NN
of/IN
the/DT
proximal/JJ
tubule/NN
,/,
as/IN
well/RB
as/IN
in/IN
the/DT
early/JJ
stage/NN
of/IN
ADPKD/NN
;/:
in/IN
normal/JJ
tubules/NNS
,/,
distribution/NN
is/VBZ
both/CC
apical/JJ
and/CC
basolateral/JJ
[/(
15/CD
]/)
./.
====================
Another/DT
interesting/JJ
defect/NN
in/IN
urine-concentrating/VBG
ability/NN
was/VBD
described/VBN
in/IN
the/DT
Aqp1/NN
knockout/JJ
mouse/NN
./.
====================
Although/IN
these/DT
mice/NNS
were/VBD
grossly/RB
normal/JJ
in/IN
terms/NNS
of/IN
survival/NN
and/CC
appearance/NN
,/,
they/PRP
were/VBD
vulnerable/JJ
to/TO
water/NN
deprivation/NN
and/CC
became/VBD
severely/RB
dehydrated/VBN
./.
====================
These/DT
results/NNS
suggest/VBP
that/IN
AQP1/NN
is/VBZ
required/VBN
for/IN
the/DT
formation/NN
of/IN
concentrated/JJ
urine/NN
[/(
16/CD
]/)
./.
====================
We/PRP
have/VBP
found/VBN
PKC-α/JJ
and/CC
Bcl-2/NN
associated/VBN
transcription/NN
factor/NN
to/TO
be/VB
down-regulated/VBN
in/IN
Pkd2/NN
KO/NN
MEF/NN
cells/NNS
and/CC
up-regulated/VBD
in/IN
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
Recent/JJ
observations/NNS
in/IN
animal/NN
models/NNS
of/IN
PKD/NN
have/VBP
implicated/VBN
apoptosis/NN
in/IN
its/PRP$
pathogenesis/NN
./.
====================
PKC-/NN
and/CC
Erk-dependent/JJ
pathways/NNS
are/VBP
critical/JJ
components/NNS
of/IN
the/DT
cell/NN
survival/NN
by/IN
suppressing/VBG
the/DT
apoptosis/NN
[/(
17/CD
]/)
./.
====================
We/PRP
also/RB
have/VBP
demonstrated/VBN
the/DT
role/NN
for/IN
PKD2/NN
in/IN
cellular/JJ
adhesion/NN
processes/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
ITGα4/NN
was/VBD
up-regulated/VBN
in/IN
Pkd2/NN
KO/NN
MEF/NN
cells/NNS
and/CC
down-regulated/VBN
in/IN
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
It/PRP
suggests/VBZ
that/IN
adhesion/NN
molecule/NN
such/JJ
as/IN
ITGα4/NN
may/MD
be/VB
associated/VBN
with/IN
PKD2/NN
mutation-related/VBN
pathogenesis/NN
./.
====================
In/IN
conclusion/NN
,/,
by/IN
using/VBG
the/DT
cDNA/NN
microarray/NN
technique/NN
,/,
we/PRP
have/VBP
found/VBN
several/JJ
candidate/NN
genes/NNS
that/WDT
may/MD
be/VB
involved/VBN
in/IN
cystogenesis/NN
:/:
PKCα/JJ
,/,
ITGα4/NN
and/CC
AQP1/NN
./.
====================
These/DT
genes/NNS
were/VBD
affected/VBN
by/IN
PKD2/NN
expression/NN
and/CC
may/MD
be/VB
related/JJ
to/TO
cyst/VB
formation/NN
of/IN
kidney/NN
together/RB
with/IN
the/DT
PKD2/NN
gene/NN
./.
====================
Establishment/JJ
of/IN
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEFs/NNS
./.
====================
(/(
A/NN
)/)
Semi-quantitative/JJ
reverse/JJ
transcription-PCR/NN
analysis/NN
of/IN
Pkd2/NN
gene/NN
in/IN
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
Human-/NN
or/CC
mouse-specific/JJ
PKD2/NN
primer/NN
sets/NNS
were/VBD
used/VBN
./.
====================
18s/CD
rRNA/NN
was/VBD
used/VBN
as/IN
a/DT
loading/JJ
control/NN
./.
====================
(/(
B/NN
)/)
Western/NN
blot/NN
analysis/NN
of/IN
polycystin/NN
2/CD
(/(
PC2/NN
)/)
expression/NN
in/IN
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
MEFs/NNS
,/,
mouse/NN
embryo/NN
fibroblasts/NNS
;/:
KO/NN
,/,
knockout/JJ
(/(
MEF/NN
)/)
;/:
TG/NN
,/,
transgenic/JJ
(/(
MEF/NN
)/)
;/:
KOWT/NN
,/,
knockout/JJ
wild-type/JJ
(/(
MEF/NN
)/)
;/:
TGWT/NN
,/,
transgenic/JJ
wild-type/JJ
(/(
MEF/NN
)/)
./.
====================
Clustering/NN
of/IN
gene/NN
expression/NN
patterns/NNS
in/IN
Pkd2/NN
mutant/JJ
MEF/NN
cell/NN
lines/NNS
./.
====================
We/PRP
performed/VBD
clustering/NN
analysis/NN
microarray/NN
data/NNS
between/IN
KO/NN
set/NN
ratio/NN
data/NNS
and/CC
TG/NN
set/NN
ratio/NN
data/NNS
using/VBG
the/DT
graphical/JJ
user/NN
interface/NN
(/(
GUI/LS
)/)
system/NN
./.
====================
(/(
A/NN
)/)
Gene/NN
expression/NN
profiles/NNS
of/IN
2,306/CD
probe/NN
sets/NNS
distributed/VBN
in/IN
a/DT
dendrogram/NN
./.
====================
(/(
B/NN
)/)
Line/JJ
plots/NNS
of/IN
each/DT
cluster/NN
./.
====================
KO/NN
set/NN
,/,
ratio/NN
between/IN
KO/NN
MEF/NN
and/CC
KOWT/NN
MEF/NN
;/:
TG/NN
set/NN
,/,
ratio/NN
between/IN
TG/NN
MEF/NN
and/CC
TGWT/NN
MEF/NN
./.
====================
MEFs/NNS
,/,
mouse/NN
embryo/NN
fibroblasts/NNS
;/:
KO/NN
,/,
knockout/JJ
(/(
MEF/NN
)/)
;/:
TG/NN
,/,
transgenic/JJ
(/(
MEF/NN
)/)
;/:
KOWT/NN
,/,
knockout/JJ
wild-type/JJ
(/(
MEF/NN
)/)
;/:
TGWT/NN
,/,
transgenic/JJ
wild-type/JJ
(/(
MEF/NN
)/)
./.
====================
Expression/NN
verification/NN
of/IN
candidate/NN
genes/NNS
at/IN
the/DT
mRNA/NN
level/NN
./.
====================
(/(
A/NN
)/)
Microarray/NN
data/NNS
for/IN
selective/JJ
genes/NNS
including/VBG
PPARγ/NN
,/,
PKCα/JJ
,/,
Wnt4/NN
,/,
ITGα4/NN
,/,
IL6ST/NN
,/,
AQP1/NN
,/,
and/CC
TGF-β2/NN
./.
====================
(/(
B/NN
,/,
C/NN
)/)
Real-time/NN
reverse/JJ
transcription-PCR/NN
analysis/NN
of/IN
gene/NN
expression/NN
for/IN
selective/JJ
genes/NNS
in/IN
Pkd2/NN
KO/NN
and/CC
PKD2/NN
TG/NN
MEF/NN
cells/NNS
./.
====================
β-actin/NN
primer/NN
was/VBD
used/VBN
as/IN
the/DT
internal/JJ
control/NN
./.
====================
The/DT
experiment/JJ
was/VBD
performed/VBN
in/IN
triplicate/NN
./.
====================
PPAR-γ/RB
,/,
peroxisome/DT
proliferator-activated/JJ
receptor/NN
γ/RB
;/:
PKCα/NNP
,/,
protein/NN
kinase/NN
α/RB
;/:
ITGα4/NN
,/,
integrin/NN
α4/NN
;/:
AQP1/NN
,/,
aquaporin/NN
1/CD
;/:
TGF-β2/NN
,/,
transforming/VBG
growth/NN
factor-β2/NN
;/:
KO/NN
,/,
knockout/RB
;/:
TG/NN
,/,
transgenic/JJ
;/:
MEF/NNP
,/,
mouse/NN
embryo/JJ
fibroblasts/NNS
;/:
KOWT/NN
,/,
knockout/RB
wild-type/JJ
(/(
MEF/NN
)/)
;/:
TGWT/NN
,/,
transgenic/JJ
wild-type/JJ
(/(
MEF/NN
)/)
./.
====================
Expression/NN
verification/NN
of/IN
AQP1/NN
at/IN
the/DT
protein/NN
level/NN
./.
====================
(/(
A/NN
)/)
Western/NN
blot/NN
analysis/NN
of/IN
AQP1/NN
in/IN
MEFs/NNS
and/CC
kidney/NN
tissues/NNS
derived/VBN
from/IN
Pkd2/NN
KO/NN
(/(
or/CC
heterozygote/NN
)/)
and/CC
PKD2/NN
TG/NN
mice/NNS
./.
====================
PKD2/NN
TG/NN
and/CC
TGWT/NN
mice/NNS
:/:
18/CD
mo/NN
;/:
Pkd2/NN
heterozygote/NN
and/CC
KOWT/NN
mice/NNS
:/:
12/CD
mo/NN
./.
====================
Anti-β-actin/NN
was/VBD
used/VBN
as/IN
the/DT
internal/JJ
control/NN
./.
====================
(/(
B/NN
)/)
For/IN
quantification/NN
of/IN
western/NN
blot/NN
,/,
Multigauge/JJ
software/JJ
(/(
Fuji/NN
Film/NN
)/)
was/VBD
used/VBN
./.
====================
AQP1/NN
,/,
aquaporin/NN
1/CD
;/:
MEF/NN
,/,
mouse/NN
embryo/NN
fibroblasts/NNS
;/:
KO/NN
,/,
knockout/JJ
;/:
TG/NN
,/,
transgenic/JJ
;/:
KOWT/NN
,/,
knockout/JJ
wild-type/JJ
(/(
MEF/NN
)/)
;/:
TGWT/NN
,/,
transgenic/JJ
wild-type/JJ
(/(
MEF/NN
)/)
./.
====================
Genes/NNS
deregualted/VBN
by/IN
differential/JJ
Pkd2/NN
expression/NN
====================
